Parathyroid hormone increases bone formation and improves mineral balance in vitamin D-deficient female rats.
The present study was designed to investigate whether enhanced bone formation due to intermittent PTH administration is dependent on vitamin D metabolites. Forty-eight female Sprague-Dawley rats were randomized into four groups: 1) vitamin D-sufficient, saline-injected (+D Sal); 2) vitamin D-sufficient, human (h) PTH-(1-38)-treated (+D PTH); 3) vitamin D-deficient, saline-injected (-D Sal); and 4) vitamin D-deficient, hPTH-(1-38)-treated (-D PTH) animals. The -D diet contained 2% calcium (Ca), 1.25% phosphorus (P), and 20% lactose to maintain normocalcemia and normophosphatemia despite vitamin D deficiency. The +D diet contained 0.8% Ca, 0.5% P, 20% lactose, and 1000 IU/kg vitamin D. After 45 days of either diet, the rats were injected with 50 microg/kg BW PTH or saline, s.c., daily for 2 weeks. Serum Ca, Mg, P, albumin, and creatinine were similar in all groups. PTH administration decreased endogenous PTH concentrations in the -D PTH compared with those in the - D Sal group. Serum alkaline phosphatase activity, bone mass measurements, dual energy x-ray absortiometric analysis of mineral density, and mechanical testing values in vertebrae and femora of the -D Sal animals did not significantly differ from those in +D Sal animals. Moreover, in both diet groups, PTH improved bone biochemical activity (as assessed by serum alkaline phosphatase), bone mass, mineral density, and biomechanical properties. These results indicate that mineral supply, more than vitamin D itself, may be important for normal bone mineralization and to enable PTH to enhance bone formation. A balance study performed during the last 3 days of the experiment revealed that PTH increased apparent intestinal magnesium absorption in the +D group only. Ca and P retention, however, were augmented in both diet groups after PTH treatment. In conclusion, in normocalcemic and normophosphatemic -D rats, PTH treatment reduced the increased endogenous hormone concentration and improved Ca and P retention. Furthermore, PTH may have a vitamin D-dependent influence on intestinal magnesium absorption. Finally, short term PTH treatment is anabolic in bone of vitamin D-deficient rats when adequate mineral amounts are provided in the diet.
Toromanoff
A
A
University of Zurich, Institute of Animal Nutrition, Switzerland. toro@vetphys.unizh.ch
Ammann
P
P
Mosekilde
L
L
Thomsen
J S
JS
Riond
J L
JL
D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D001696:Biomechanical Phenomena; D015519:Bone Density / Q000187:drug effects / Q000502:physiology*; D001846:Bone Development / Q000187:drug effects / Q000502:physiology*; D002118:Calcium / Q000097:blood / Q000652:urine; D002136:Calcium, Dietary; D003404:Creatinine / Q000097:blood; D004032:Diet; D005260:Female; D005269:Femur / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology; D006801:Humans; D066298:In Vitro Techniques; D007408:Intestinal Absorption; D008159:Lumbar Vertebrae / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology; D008274:Magnesium / Q000097:blood / Q000652:urine; D010281:Parathyroid Hormone / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology*; D010710:Phosphates / Q000097:blood / Q000652:urine; D010758:Phosphorus; D051381:Rats; D017207:Rats, Sprague-Dawley; D013314:Stress, Mechanical; D014807:Vitamin D / Q000494:pharmacology*; D014808:Vitamin D Deficiency / Q000378:metabolism / Q000503:physiopathology*
D002136:Calcium, Dietary; D010281:Parathyroid Hormone; D010446:Peptide Fragments; D010710:Phosphates; C035747:parathyroid hormone (1-38); D014807:Vitamin D; D010758:Phosphorus; D003404:Creatinine; D000469:Alkaline Phosphatase; D008274:Magnesium; D002118:Calcium